Clinical Trial

Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism

Study acronym: GAPA
Recruiting
View on ClinicalTrials.gov →
Summary
To compare the 68Ga-Pentixafor PET/CT and adrenal vein sampling on the long-term outcomes of primary aldosteronism (PA) patients with adrenal nodule (≥1cm)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-01.
Trial Details
NCT Number NCT06238232
Lead Sponsor Qifu Li
Collaborators: The Affiliated Hospital Of Southwest Medical University, West China Hospital, Tongji Hospital, The First Affiliated Hospital of Zhengzhou University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Third Xiangya Hospital of Central South University, Second Affiliated Hospital, Zhejiang University, School of Medicine, Changzhi Medical College, Xiangya Hospital of Central South University
Conditions Primary Aldosteronism
Enrollment 320 participants
Start Date 2024-01-09
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-30